住院老年2型糖尿病空腹低血糖分析
Analysis of Fasting Hypoglycemia in Hospitalized Elderly Patients with Type 2 Diabetes Mellitus
DOI: 10.12677/ACM.2020.106136, PDF,    科研立项经费支持
作者: 祝 盼, 陈 瞳, 张杰涛*:青岛大学附属医院,山东 青岛;孙晓东:潍坊医学院,山东 潍坊
关键词: 老年人糖尿病2型住院低血糖症胰岛素Elderly People Diabetes Type 2 Inpatients Hypoglycemia Insulin
摘要: 目的:回顾性分析住院老年2型糖尿病(T2DM)患者空腹低血糖(空腹血糖≤3.9 mmol/L)发生状况,分析不同胰岛素种类其空腹低血糖发生情况,为老年糖尿病治疗提供参考依据。方法:通过我院住院患者数据库,检索2012年1月1日至2018年7月31日在我院住院的年龄65岁及以上的T2DM患者,1) 根据用药是否包含胰岛素分为胰岛素组(1组)和非胰岛素组(2组)。2) 应用预混胰岛素的患者为A组,应用长效胰岛素的患者为B组。3) 依据出院科室分组,内分泌科患者为C组,非内分泌科患者为D组,比较各组空腹低血糖发生率有无差异。结果:1) 2组空腹低血糖发生率高于1组(P < 0.05);按照年龄分层后差异有统计学意义(P < 0.05)。2) A组空腹低血糖发生率高于B组(P = 0.001);按照年龄分层后,[75, 80]及80岁以上年龄段差异有统计学意义(P < 0.05)。3) C组患者空腹低血糖发生率与D组无差异(P > 0.05);C组预混胰岛素应用比例低于D组(P < 0.05)。4) 在空腹血糖≤3.9 mmol/L的患者中,应用最多的降糖方案为口服降糖药物联合胰岛素(32.09%),其次为单用胰岛素者(24.04%),单用口服降糖药物者比例最少(20.94%)。结论:随年龄增加,老年T2DM患者空腹低血糖发生率呈逐渐升高的趋势;年龄在75岁及以上的T2DM患者中,应用预混胰岛素空腹低血糖发生率更高。
Abstract: Objective: To retrospectively analyze the occurrence of fasting hypoglycemia in elderly patients with type 2 diabetes mellitus in Qingdao University Affiliated hospital, and to analyze the difference of incidence of fasting hypoglycemia in different insulin types and hypoglycemic regimens, and to provide reference for the treatment of senile diabetes mellitus. Methods: Through the database of inpatients in our hospital, the type 2 diabetic patients aged 65 and above who were hospitalized at Qingdao University Affiliated hospital from January 1, 2012 to July 31, 2018 were retrieved, 1) The patients were divided into insulin group (group 1) and non-insulin group (group2) according to whether insulin was included in the medicine. 2) The patients with hypoglycemic drugs containing premixed insulin were group A and group B with long-acting insulin. 3) According to the group of discharged departments, the endocrine department is group C, non-endocrine patients are group D, compare the incidence of fasting hypoglycemia in different groups. Results: 1) In hospitalized elderly patients with type 2 diabetes mellitus, the incidence of fasting hypoglycemia in group 2 was higher than that in group 1, (P < 0.05); after grouping according to age, there was significant difference between the two groups (P < 0.05). 2) The incidence of fasting hypoglycemia in Group A was higher than that in group B (P = 0.001); after grouping according to the age, in patients between [75, 80] and above 80 years old, the incidence of fasting hypoglycemia in group A was higher than that in group B (P < 0.05). 3) Grouping by department, there was no difference between the incidence of fasting hypoglycemia in group C and group D (P > 0.05); the proportion of premixed insulin used in group C was lower than group D (P < 0.05). 4) In patients with fasting blood glucose ≤ 3.9 mmol/L, the most widely used hypoglycemic scheme is oral hypoglycemic drug combined with insulin (32.09%), followed by insulin alone (24.04%), oral hypoglycemic drugs alone accounted for the least proportion (20.94%). Conclusion: With the increase of age, the incidence of fasting hypoglycemia in elderly patients with T2DM increased gradually; the incidence of fasting hypoglycemia with premixed insulin was higher in type 2 diabetic patients aged 75 years and over.
文章引用:祝盼, 陈瞳, 孙晓东, 张杰涛. 住院老年2型糖尿病空腹低血糖分析[J]. 临床医学进展, 2020, 10(6): 890-898. https://doi.org/10.12677/ACM.2020.106136

参考文献

[1] Hu, C. and Jia, W. (2018) Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication. Diabetes, 67, 3-11.
[Google Scholar] [CrossRef] [PubMed]
[2] Wang, L., Gao, P., Zhang, M., et al. (2017) Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA, 317, 2515.
[Google Scholar] [CrossRef] [PubMed]
[3] Fukuda, M., Doi, K., Sugawara, M., et al. (2015) Survey of Hypoglycemia in Elderly People With Type 2 Diabetes Mellitus in Japan. Journal of Clinical Medicine Research, 7, 967-978.
[Google Scholar] [CrossRef] [PubMed]
[4] 方团育, 陈开宁, 全会标, 等. 高龄糖尿病住院患者发生低血糖的危险因素分析[J]. 山东医药, 2016, 56(22): 74-76.
[5] Akram, K., Pedersen-Bjergaard, U., Borch-Johnsen, K., et al. (2006) Frequency and Risk Factors of Severe Hypoglycemia in Insulin-Treated Type 2 Diabetes: A Literature Survey. Journal of Diabetes & Its Complications, 20, 402-408.
[Google Scholar] [CrossRef] [PubMed]
[6] Schopman, J.E., Geddes, J. and Frier, B.M. (2010) Prevalence of Impaired Awareness of Hypoglycaemia and Frequency of Hypoglycaemia in Insulin-Treated Type 2 Diabetes. Diabetes Research & Clinical Practice, 87, 64-68.
[Google Scholar] [CrossRef] [PubMed]
[7] Ratzki-Leewing, A., Harris, S.B., Mequanint, S., et al. (2018) Real-World Crude Incidence of Hypoglycemia in Adults with Diabetes: Results of the InHypo-DM Study, Canada. BMJ Open Diabetes Research & Care, 6, e000503.
[Google Scholar] [CrossRef] [PubMed]
[8] Živković, T.M.B., Đinđić, B.J., Toljić, D.Ž.Š., et al. (2018) Unmet Needs in the Management of Type 2 Diabetes Mellitus Patients Starting Insulin Therapy with Basal or Premix Insulin in Routine Clinical Practice in Serbia. Diabetes Therapy, 10, 71-80.
[Google Scholar] [CrossRef] [PubMed]
[9] Hussain, J. (2008) Standards of Medical Care in Diabetes—2008. Diabetes Care, 34, S11-S61.
[Google Scholar] [CrossRef
[10] Matthaei, S., Bierwirth, R., Fritsche, A., et al. (2009) Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus: Update of the Evidence-Based Guideline of the German Diabetes Association. Experimental and Clinical Endocrinology and Diabetes, 117, 522-557.
[Google Scholar] [CrossRef] [PubMed]
[11] Tiruneh, G.G., Abebe, N. and Dessie, G. (2019) Self-Reported Hypoglycemia in Adult Diabetic Patients in East Gojjam, Northwest Ethiopia: Institution Based Cross-Sectional Study. BMC Endocrine Disorders, 19, Article No.: 17.
[Google Scholar] [CrossRef] [PubMed]
[12] Association, A.D. (2010) Standards of Medical Care in Diabetes—2010. Diabetes Care, 33, S11-S61.
[Google Scholar] [CrossRef
[13] Turchin, A., Matheny, M.E., Shubina, M., et al. (2009) Hypoglycemia and Clinical Outcomes in Patients with Diabetes Hospitalized in the General Ward. Diabetes Care, 32, 1153-1157.
[Google Scholar] [CrossRef] [PubMed]
[14] Eliasson, B., Ekström, N., Bruce Wirta, S., et al. (2014) Metabolic Effects of Basal or Premixed Insulin Treatment in 5077 Insulin-Naïve Type 2 Diabetes Patients: Registry-Based Observational Study in Clinical Practice. Diabetes Therapy, 5, 243-254.
[Google Scholar] [CrossRef] [PubMed]
[15] Bellido, V., Suarez, L., Rodriguez, M.G., et al. (2015) Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients with Type 2 Diabetes. Diabetes Care, 38, 2211-2216.
[Google Scholar] [CrossRef] [PubMed]
[16] Sheu, H.H., Ji, L., Lee, W.J., et al. (2017) Efficacy and Safety of Premixed Insulin Analogs in Asian Patients with Type 2 Diabetes: A Systematic Review. Journal of Diabetes Investigation, 8, 518-534.
[Google Scholar] [CrossRef] [PubMed]
[17] Lipska, K.J., Warton, E.M., Huang, E.S., et al. (2013) HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes. Diabetes Care, 36, 3535-3542.
[Google Scholar] [CrossRef] [PubMed]
[18] Lee, A.K., Lee, C.J., Huang, E.S., et al. (2017) Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care, 40, 1661-1667.
[Google Scholar] [CrossRef] [PubMed]
[19] Naser, A.Y., Wong, I.C.K., Whittlesea, C., et al. (2018) Use of Multiple Antidiabetic Medications in Patients with Diabetes and Its Association with Hypoglycaemic Events: A Case-Crossover Study in Jordan. BMJ Open, 8, e024909.
[Google Scholar] [CrossRef] [PubMed]